Applications published 31 December 2008

• Osmotic dosage form
McNeil-PPC 2007346*

• Compsn comprising an agent for stabilising active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof
Lohrmann Animal Health 2007347*

• Paediatric amino acid solution for parenteral nutrition
Fresenius Kabi Deutschland 2007348*

• Aerosol suspension formulations comprising TG 227 EA or TG 134 A as propellants
Boehringer Ingelheim Pharma 2007349*

• Degradable therapeutic delivery device
Kimberley-Clark Worldwide 2007350*

• Polymeric materials as stomach filler and their preparation
Gelesis; Exotech Bio Solutions 2007351*

• Treatment of psychiatric patients with sleep disturbances and/or excessive daytime sleepiness with paliperidone
Janssen Pharmaceutica 2007352*

• Drug depot implant designs and methods of implantation
Warsaw Orthopaedic 2007353*

• Brimonide and timolol compsns
Allergan 2007354*

• Liposomal compsns
Wyeth 2007355*

• Lipoplex formulations for specific delivery to vascular endothelium
Silence Therapeutics 2007356*

• Compsns of less immunogenic and long-circulating protein-lipid complexes
The Research Foundation of State University of New York 2007357*

• Swellable particles for drug delivery
STC. UNM 2007358*

• Dosage forms having a randomised coating
McNeill-PPC 2007359*

• Controlled release delivery device comprising an organosol coat
Odidi, Isa; Odidi, Amina 2007360*

• Film-coated solid dosage forms
McNeil-PPC 2007361*

• Oral dosage forms including an antiplatelet agent and an acid inhibitor
Cogentus Pharmaceuticals 2007362*

• Transcription factor modulator
BioPharmica 2007364*

• Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
PTC Therapeutics 2007365*

• Use of rasagiline for the treatment of restless legs syndrome
Teva Pharmaceutical Industries 2007369*

• Novel compsns for tumour growth control
Erasmus University Medical Centre Rotterdam 2007370*

• Lactate and calcium containing pharmaceutical compsn and uses thereof
Innogene Kalbiotech 2007371*

• Dialkyl ether delivery agents
Emisphere Technologies 2007372*

• Inhibition of alpha-synuclein toxicity
Foldrx Pharmaceuticals; Whitehead Institute for Biomedical Research 2007373*

• Antispermatogenic, spermicidal and/or antifungal compsn and methods of using the same
Research Triangle Institute; Tallent, Clyde; Thomas, Brian; Navarro, Hernan; Cook, Kevin 2007374*

• Combination therapy of (2R,Z)-2-amino-2-cyclohexyl-N-(5-(1-methyl-1H-pyrazol-4-yl)-1-oxo-2,6-dihydro-1H-[1,2]diazepino[4,5,6-CD]indol-8-yl)acetamide
Pfizer 2007375*

• Therapeutic uses of cannabinol compounds
Hadasit Medical Research Services and Development; Yissum Research Development Company of the Hebrew University of Jerusalem 2007376*

• Antibacterial agents
Glaxo Group 2007377*

• Pharmaceutical compsn comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom
Amorepacific 2007378*

• Use of a kinase inhibitor for the treatment of particularly resistant tumours
Nerviano Medical Services 2007380*

• Compsns and methods of use of ritonavir for treating HCV
Abbott Laboratories 2007381*

• Thiazolyldihydrocyclopentapyrazoles for use as P13-kinase inhibitors
Boehringer Ingelheim International 2007382*

• Inhibition of protein prenyl-transferases
The Regents of the University of California 2007383*

• Orodispersible domperidone tablets
Pierre Fabre Medicament 2007384*

• Cardiovascular compsn and use of the same for the treatment of Alzheimer’s disease
Mount Sinai School of Medicine 2007385*

• Camptothecin-analogue with a novel, flipped lactone-stable, E-ring and methods for making and use same
Bionumerik Pharmaceuticals 2007386*

• Compsns and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
Shire LLC 2007389*

• Combination comprising a) a pyrimidylaminobenzamide compound, and b) a THR315LLE kinase inhibitor
Novartis 2007391*

• Method of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
Elan Pharmaceuticals 2007392*

• Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College 2007393*

• Novel use of antihistamine agents for the prevention or early treatment of inflammatory syndromes, in particular those triggered by togaviruses
Pierre Fabre Medicament 2007394*

• CGRP antagonist salt
Merck 2007395*

• Antifungal agents
Merck; Scynexis 2007396*

• Solid oral dosage form containing an enhancer
Merrion Research 2007397*

• High delivery rates for lipid based drug formulations, and methods of treatment thereof
Transave 2007398*

• Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases
Ester Neurosciences 2007399*

• New medicines for treatment against retroviruses
Laboratoires de la Mer 2007400*

• Anti-inflammatory polymer
Merinomed Biotechnologie 2007401*

• Antiviral methods
Agion Technologies 2007402*

• Methods and systems for treating injured cardiac tissue
Medtronic Vascular 2007403*

• Nutritional compsns for promotion of bone growth and maintenance of bone health and methods regarding same
Nestec 2007406*